Cable Hill Partners, LLC Sage Therapeutics, Inc. Transaction History

Cable Hill Partners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 06, 2019	SELL	$157.85 - $183.09 $2,999 - $3,478	-19 Closed	0 $0
Q1 2019 May 10, 2019	SELL	$89.33 - $163.65 $1,339 - $2,454	-15 Reduced 44.12%	19 $3,000
Q3 2018 Nov 14, 2018	SELL	$138.11 - $169.04 $828 - $1,014	-6 Reduced 15.0%	34 $5,000
Q1 2018 Apr 20, 2018	SELL	$152.15 - $192.33 $10,041 - $12,693	-66 Reduced 62.26%	40 $6,000
Q3 2017 Oct 27, 2017	SELL	$61.4 - $88.52 $122 - $177	-2 Reduced 1.85%	106 $7,000
Q2 2017 Aug 14, 2017	BUY	N/A	108	108 $9,000

198

46.5M

402K

209K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $326M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Cable Hill Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Cable Hill Partners, LLC with notifications on news.